Proactive - Interviews for investors

Fah Mai Holdings UK head and manager of @whiskybullauctions Jacob Carter takes Proactive's Stephen Gunnion through the process of selling at auction.

Initial contact can be made through the website’s chat box, email, or phone. Sellers need to provide a complete list of the whisky they wish to auction. Fah Mai Holdings ensures transparency in pricing, providing honest valuations based on current market trends.

Carter explained that the company charges a 7% commission to the buyer, with free membership, listing, and reserve fees. Storage costs £1 per year per bottle. Additionally, sellers receive an extra 1% on the hammer price. Sellers can send bottles directly to the company or use their insured collection service.

Whisky Bull Auctions conducts two auctions per month, each lasting 2 to 4 days. Types of auctions include no reserve, branded, and quarterly cask auctions. Auctions feature bottles and casks from global offices in New Jersey and Singapore. After the auction, sellers are provided with detailed receipts and are kept informed throughout the process.

#FahMaiHoldings #JacobCarter #WhiskeyAuctions #ProactiveLondon #SellWhiskey #AuctionGuide #WhiskeyCollection #TransparentValuations #AuctionCommission #GlobalAuctions #WhiskeyBullAuctions #CaskAuctions #WhiskeyStorage #AuctionProcess #UKHead #MarketTrends #WhiskeySales #AuctionTips #ValuationProcess #InsuredService #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Ilika PLC CEO Graeme Purdy discusses the company’s positive trading update for the year to 30 April 2024 with Proactive London’s Stephen Gunnion.

The company expects to announce revenues of approximately £2.1 million from £0.7 million a year earlier and ended the period with cash and cash equivalents of £11.9 million, providing a solid foundation for future operations.

Key highlights included a ten-year licensing agreement with Cirtec Medical LLC in the US to commercialise miniature batteries for medical devices and wireless sensors. Additionally, Ilika announced a 12-month collaboration with the Tata Group’s Agratas to develop Goliath cells, aiming for a 50 amp-hour battery by the first half of 2025.

The company’s financial position is supplemented by a recent £1.7 million capital raise aimed at advancing the Goliath programme. Planned investments include upgrading dry room capabilities to handle moisture-sensitive materials and enhancing testing equipment for larger battery prototypes.

Purdy also provided an update on the Stereax production line, noting significant progress at the Massachusetts facility, with equipment commissioning and qualification underway.

#Ilika, #GraemePurdy, #TradingUpdate, #RevenueGrowth, #EBITDA, #FinancialResults, #LicensingAgreement, #CiticMedical, #GoliathCells, #TataGroup, #Agratas, #BatteryDevelopment, #CapitalRaise, #Stereax, #MedicalDevices, #WirelessSensors, #BatteryTechnology, #Innovation, #ProactiveLondon, #FinancialYear, #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

The FTSE 100 edged lower as trading got underway on Friday, following last night’s close in the red.

Among those falling was Land Securities Group, which unveiled reduced earnings and a loss for 2023 on the back of a lower valuation for its property portfolio.

GSK also dipped as the market opened after announcing the sale of its stake in Haleon for £1.25 billion.

Sainsbury’s rose in the meantime on the back of a new partnership with Microsoft to roll out AI across its supermarkets, including to aid with restocking and introducing new products.

And finally, among small caps, IQ-AI jumped on news its advanced imaging software had been successfully installed by Swiss hospital group Insel Gruppe.

#ProactiveInvestors #marketreport #ftse #ftse100 #footsie #landsecuritiesgroup #gsk #haleon #sainsbury's iq-ai #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Sunstone Metals Ltd (ASX:STM) managing director Patrick Duffy joins Elisha Newell in the Proactive studio soon after completing a site visit at the company’s gold and copper prospects in Ecuador.

The precious and base metal explorer is progressing towards a sizeable maiden resource at its El Palmar T1 porphyry discovery, where recent assays from trenching revealed substantial surface mineralisation.

Notable results include 40.4 metres at 0.86 g/t gold and 524 ppm copper in trench P6-7d and 21 metres at 0.34 g/t gold and 714 ppm copper in trench P6-7c, with both trenches open on all sides.

Commenting on the gold and copper findings, Duffy highlighted the extent and shallow nature of the El Palmar mineralisation — characteristics which are certain to guide the explorer’s future drilling programs.

Beyond the next phase of work, Sunstone plans to incorporate the trenching assays into a maiden resource, assess the potential for mineralisation beyond the original T1 target and test targets T1, T2, and T5.

The news comes soon after the company announced it was raising up to $6.3 million from new and existing institutional, professional and sophisticated investors to support its Ecuadorian exploration programs.

An oversubscribed placement in early May brought in a $2 million war chest, while a non-renounceable rights issue could raise up to $4.3 million before costs.

Proceeds will help Sunstone resume drilling operations at the Limon epithermal discovery and sustain exploration across the El Palmar and Verde Chico sites.

#ProactiveInvestors #SunstoneMetals #ASX #ElPalmar #GoldCopperDiscovery #Mineralisation #TrenchingResults #PorphyryDiscovery #EcuadorMining #ResourceEstimate #GoldGrades #CopperGrades #SurfaceMineralisation

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Mediazest PLC CEO Geoff Robertson gives Proactive's Stephen Gunnion an overview of the company's operations and recent developments.

Mediazest, an audiovisual solutions provider, operates in markets such as retail, automotive showrooms, and workspace offices. The company, established nearly 20 years ago, counts well-known brands like Pets at Home, Hyundai, and Jaguar Land Rover among its clients. Mediazest focuses on a holistic, consultative approach, ensuring high-quality delivery and ongoing support.

Robertson highlighted the company's European expansion with a Dutch subsidiary established in late 2022, which has enabled better service for EU clients. Following a challenging 2023, Mediazest has seen improvements in 2024, with a positive trading update indicating a strong first half and a promising second half of the year. Robertson mentioned the potential for both organic growth and acquisitions to expand their market presence, noting the ripe conditions for consolidations within the industry.

Looking ahead, Mediazest aims to capitalise on opportunities in digital signage, electric vehicle showrooms, and hybrid meeting technologies. Robertson expressed optimism about the company's ability to leverage these trends and deliver value to its clients.

#Mediazest #GeoffRobertson #AVSolutions #ProactiveLondon #DigitalSignage #RetailTech #AutomotiveShowrooms #WorkspaceSolutions #EuropeanExpansion #ClientSupport #TradingUpdate #2024Growth #OrganicGrowth #Acquisitions #DigitalTransformation #HybridMeetings #ElectricVehicles #ClientSuccess #TechnologyTrends #BusinessGrowth

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Arecor Therapeutics PLC (AIM:AREC)C CEO Sarah Howell discusses the company's 2023 performance and future plans with Proactive's Stephen Gunnion.

Howell highlighted that Arecor has seen significant growth, particularly with the launch of products incorporating its Arestat technology under a global licensing agreement, generating royalties. Six new technology partnerships were established with major pharma and biotech companies, offering potential for future licensing and market development.

Arecor focuses on diabetes and obesity, with clinical results for their proprietary product, AT278, expected soon. This highly concentrated, rapid-acting insulin aims to provide better glucose control for type 2 diabetics with high BMI and support the next generation of insulin pump devices.

Tetris Pharma, a subsidiary, has shown strong growth under new leadership, with product sales tripling to £2.9 million in 2023. Its lead product, glucagon, has contributed significantly to this growth.

Howell also noted the importance of technology partnerships and licensing programs. Arecor has entered into three active license programs and is progressing well with its partners. One notable partnership is with Medtronic to develop a concentrated, stable insulin for intra-peritoneal delivery, aiming to reduce hospital visits for patients with brittle diabetes.

#ArecorTherapeutics, #Pharma, #Biotech, #Diabetes, #Obesity, #Insulin, #Glucagon, #TetrisPharma, #ClinicalTrials, #ArestatTechnology, #Medtronic, #RoyaltyRevenue, #Partnerships, #Licensing, #Innovation, #Healthcare, #PatientCare, #DrugDevelopment, #MarketGrowth, #2023Results

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Neural Therapeutics CEO Ian Campbell discusses the company's conditional approval to list on the Canadian Securities Exchange (CSC) in an interview with Proactive's Stephen Gunnion.

Campbell explained that the CSE listing is a strategic move, enabling broader market participation and capitalisation on its advancements. The company aims to raise $500,000, primarily for research and development efforts and securing intellectual property, including two patents.

Campbell highlighted the growing interest in psychedelic treatments, noting the significant investment in this sector and the 44% rise of the Psychedelic Invest Index this year. He emphasised the mental health crisis and the inadequacy of outdated therapies, positioning psychedelics as a promising and disruptive alternative.

Neural Therapeutics specialises in mescaline extracted from the San Pedro cactus, a substance with a long history of safe use. Campbell noted mescaline's unique properties, such as its longer duration in the body, which supports neuroplasticity and potential treatment for mental illnesses like addiction without causing hallucinations.

The CSE listing is expected to enhance the company's visibility, attract investment, and accelerate drug development.

#NeuralTherapeutics, #PsychedelicTreatments, #MentalHealth, #CSCListing, #Investing, #Mescaline, #SanPedroPlant, #ResearchAndDevelopment, #IntellectualProperty, #Psychedelics, #MentalHealthCrisis, #Innovation, #DrugDevelopment, #Neuroplasticity, #SafeUse, #AddictionTreatment, #PharmaceuticalIndustry, #InvestmentOpportunity, #Growth, #StrategicMove #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Empire Metals Ltd (AIM:EEE) managing director Shaun Bunn discusses the results from the final 22 reverse circulation (RC) holes at the company's Pitfield project in Western Australia with Proactive's Stephen Gunnion.

The drilling campaign targeted two key areas, the Cosgrove and Thomas prospects, each spanning approximately 25 km². Bunn highlighted that every hole intercepted high-grade titanium from surface to depth, indicating the presence of a highly weathered cap with up to 15% higher grade at the surface.

Additionally, Bunn mentioned the completion of four diamond drill holes with excellent core recovery, pending analytical results. These core samples are critical for mapping geological structures and obtaining metallurgical and mineralogical data. The drilling program comprised 107 holes, covering over 17,000 metres, including seven diamond drill holes.

Bunn explained that the company has mapped a giant mineral system over 30 to 40 km in strike length, with the deepest drilling reaching 400 metres. The focus is now on higher-grade sandstone-dominated systems near the surface at the Cosgrove and Thomas prospects. The next steps include delineating chalk exploration targets and determining the tonnage and scale of these deposits.

Empire Metals has engaged Snowden Optiro to provide geological expertise and ensure compliance with JORC standards. Snowden will assist in preparing geological models and defining high-grade zones, working closely with the exploration team.

#EmpireMetals #ShaunBunn #PitfieldProject #TitaniumDrilling #RCDrilling #DiamondDrilling #GeologicalMapping #MineralExploration #CauseGrave #ThomasProspect #HighGradeTitanium #MetallurgicalSamples #GeologicalStructures #ExplorationTargets #SnowdenConsultants #JORCCompliance #MiningNews #CoreRecovery #DrillingResults #MineralSystem #MiningUpdate

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease and the company’s developments in treating it.

Kohlhof explained that celiac disease is a severe autoimmune disorder affecting around 1% of the global population, predominantly females. Unlike gluten intolerance, celiac disease involves an immune reaction to gluten, leading to gut inflammation and destruction. The only current treatment is a gluten-free diet, which is not effective for all patients.

Kohlhof elaborated on the disease's scientific background, highlighting its genetic association with specific HLA genotypes (HLA-DQ2 and HLA-DQ8). She explained that celiac disease is triggered by the immune system's reaction to deaminated gluten peptides, causing inflammation and damage to the gut lining.

Immunic is developing IMU-856, an epigenetic modulator, to treat gastrointestinal diseases like celiac disease. IMU-856 enhances gut regeneration and strengthens the gut barrier, improving patients' conditions.

Kohlhof detailed the successful completion of a Phase 1b study in celiac patients, which demonstrated the drug’s safety, good pharmacokinetic properties, and positive effects on symptoms, biomarkers, gut histology, and nutrient uptake during a gluten challenge. The study confirmed the potential of IMU-856 in treating celiac disease, and further exploration of its mode of action is ongoing.

#ImmunicInc, #CeliacDisease, #AutoimmuneDisorder, #GlutenFree, #HellaKohlhof, #ScientificResearch, #EpigeneticModulator, #IMU856, #GutHealth, #Phase1bStudy, #GlutenChallenge, #GastrointestinalDiseases, #Biotechnology, #MedicalResearch, #HealthInnovation, #Pharmacokinetics, #GeneticResearch, #ImmuneSystem, #Healthcare,

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Chariot Ltd (AIM:CHAR, OTC:OIGLF) technical director Duncan Wallace discusses the company's onshore Morocco drill program following results from the RZK-1 well on the Gaufrette prospect.

Despite the first well not resulting in a commercial discovery, Wallace highlighted positive findings such as better-than-expected reservoir quality and significant gas peaks. The well was drilled on time and on budget, demonstrating the company’s operational efficiency. The preliminary view suggests the gas play is promising.

Chariot is now shifting focus to a second well on the Dartois prospect, targeting a different reservoir system. This well is expected to provide further insights into the area’s potential. Wallace remains optimistic, noting that past drilling in the region has indicated the presence of gas.

Wallace explained that the company has two major projects in the region: offshore development and exploration in partnership with energy companies, and an onshore exploration license obtained in mid-2023.

He emphasised that this year is pivotal for Chariot, with significant drilling activities both onshore and offshore. The offshore project could be transformative, potentially delivering a substantial gas development and enhancing Morocco's energy security.

#ChariotLimited, #Morocco, #OnshoreDrilling, #GasExploration, #EnergySector, #TechnicalDirector, #DuncanWallace, #OffshoreDevelopment, #EnergySecurity, #GasDiscovery, #IndustrialGasDemand, #ExplorationCampaign, #GasReservoirs, #3DSeismic, #FastTrackExploration, #OperationalEfficiency, #TrapIntegrity, #ReservoirQuality, #TransformationalProject, #CarbonFootprint

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews